Zeo ScientifiX, Inc.

ZEOX · OTC · SIC 2836: Biological Products, (No Diagnostic Substances)
203
SEC Filings

Business Summary

PART I . Overview We are a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company has a portfolio of proprietary products derived from ethically sourced birth tissue, including mesenchymal stem cells, stem cell and amniotic fluid derived exosomes and Whartons Jelly matrix. The Companys principal product is Zofin, a product derived from amniotic fluid a...

Next Earnings

Q2 FY2026 — expected 2026-07-19

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionZEOXdiscussed_in_filing Trusted Computing
topic_mentionZEOXdiscussed_in_filing Blockchain & Crypto
topic_mentionZEOXdiscussed_in_filing Capital Expenditure
topic_mentionZEOXdiscussed_in_filing Supply Chain
topic_mentionZEOXdiscussed_in_filing Regulation
topic_mentionZEOXdiscussed_in_filing Healthcare & Bio
topic_mentionZEOXdiscussed_in_filing Sovereign & Government
topic_mentionZEOXdiscussed_in_filing Trusted Computing
topic_mentionZEOXdiscussed_in_filing Blockchain & Crypto
topic_mentionZEOXdiscussed_in_filing Capital Expenditure
topic_mentionZEOXdiscussed_in_filing Supply Chain
topic_mentionZEOXdiscussed_in_filing Regulation
topic_mentionZEOXdiscussed_in_filing Healthcare & Bio
topic_mentionZEOXdiscussed_in_filing Sovereign & Government
topic_mentionZEOXdiscussed_in_filing Trusted Computing
topic_mentionZEOXdiscussed_in_filing Blockchain & Crypto
topic_mentionZEOXdiscussed_in_filing Capital Expenditure
topic_mentionZEOXdiscussed_in_filing Supply Chain
topic_mentionZEOXdiscussed_in_filing Regulation
topic_mentionZEOXdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-01-292025-10-310001829126-26-000763EDGAR65K words
2025-01-292024-10-310001829126-25-000536EDGAR
2024-01-292023-10-310001829126-24-000541EDGAR
2023-02-142022-10-310001829126-23-001524EDGAR
2022-02-142021-10-310001829126-22-003605EDGAR
2021-02-082020-10-310001829126-21-000414EDGAR
2020-10-162019-10-310001683168-20-003466EDGAR
2020-03-062018-10-310001683168-20-000712EDGAR
2018-11-012017-10-310001683168-18-003206EDGAR
2017-07-072016-10-310001493152-17-007610EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-03-172026-01-310001829126-26-002396EDGAR17K words
2025-09-152025-07-310001829126-25-007398EDGAR
2025-06-162025-04-300001829126-25-004512EDGAR
2025-03-172025-01-310001829126-25-001828EDGAR
2024-09-162024-07-310001829126-24-006296EDGAR
2024-06-142024-04-300001829126-24-004217EDGAR
2024-03-182024-01-310001829126-24-001677EDGAR
2023-09-142023-07-310001829126-23-006098EDGAR
2023-06-162023-04-300001829126-23-004245EDGAR
2023-03-172023-01-310001829126-23-002113EDGAR
2022-09-142022-07-310001829126-22-016867EDGAR
2022-06-142022-04-300001829126-22-013532EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001829126-26-002881EDGAR1K words
2026-03-270001829126-26-002789EDGAR
2026-01-280001829126-26-000610EDGAR
2026-01-210001829126-26-000431EDGAR
2026-01-070001829126-26-000073EDGAR
2026-01-050001829126-26-000029EDGAR
2025-12-030001829126-25-009662EDGAR
2025-10-230001829126-25-008357EDGAR
2025-07-290001829126-25-005526EDGAR
2025-07-210001829126-25-005232EDGAR

203 total filings indexed. 171 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001557376
TickerZEOX
ExchangeOTC
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 24c7b0271b2afefd335ffcc5109de001a706bf56d3747711c1b529cd6efb4412
parent: 4682193e337b76cc2cf987d958bc9a5dfc438e21e7836a0f7e5546fb1b1a1bcd
content hash: 6b9f0d97fa756bd272cf77add89b3f9dc1dbacda1d9d7f79c5a7361de8b085b3
signed: 2026-04-13T04:48:22.383Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf